Kiro Grifols
Kiro Grifols develops robotic and automated compounding systems for hospital pharmacy IV preparation, serving oncology and sterile compounding departments globally as a subsidiary of Grifols within the inclusiv portfolio.
- Company typePrivate
- Founded2010
- HeadquartersArriate, Spain
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Kiro Grifols does
Kiro Grifols S.L. is a Spanish medical technology company specializing in robotic and automated compounding systems for hospital pharmacy IV preparation. Originally established in 2010 as Kiro Robotics SL, a spin-off from the Mondragon Corporation, the company was acquired by global healthcare conglomerate Grifols in 2014 and rebranded as Kiro Grifols S.L. The company is headquartered in Arrasate-Mondragón in the Basque Country and operates as part of Grifols' inclusiv portfolio of integrated IV compounding technology, software, and service solutions.
Kiro Grifols' product portfolio addresses both hazardous and non-hazardous sterile compounding through five core offerings: KIRO Oncology (robotic system with two robotic arms, gravimetric verification, and self-cleaning for hazardous drug preparation), KIRO Fill (high-throughput automated device for non-hazardous preparations with ISO 5 aseptic environment), Gri-fill (semi-automatic system for batch and patient-specific production), KIRO Isolator (VHP sterilization robotic compounding system), and KIRO Link (web-based workflow management software with HL7-based HIS integration, KIRO Analytics, digital training, and the KIRO Network community). Systems comply with USP <797>, USP <800>, GMP, ISO 5, IEC 61010, and IEC 61326-1 certifications.
The company generates revenue through direct enterprise sales of capital equipment to hospital pharmacies worldwide, supplemented by multi-year service contracts covering deployment, qualification, periodic maintenance, airflow certifications, and dosing accuracy tests. Distribution leverages Grifols' commercial infrastructure spanning 110+ countries, with active sales engagement at major industry conferences including EAHP, ASHP Midyear, and Arab Health. Named customers include leading cancer centers and academic hospitals across Ireland, France, Canada, the United States, Spain, South Korea, and the Netherlands.
Kiro Grifols firmographics
Firmographics- Name
- Kiro Grifols
- Legal name
- Kiro Grifols, S.L.
- Website
- https://kirogrifols.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Kiro Grifols develops robotic and automated compounding systems for hospital pharmacy IV preparation, serving oncology and sterile compounding departments globally as a subsidiary of Grifols within the inclusiv portfolio.
- Ownership category
- akta.pro rank
Kiro Grifols industry classification
Industry- Product category
- Hospital Pharmacy Sterile Compounding Automation
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Compounding Pharmacy & Sterile Prep Workflow Systems (HLACAKAM)
- akta.pro secondary industry
- Pharmacy Information Systems (PIS) & Dispensing Workflow (HLACAKAC)
Keywords
Where Kiro Grifols is headquartered
LocationHeadquarters
- HQ city
- Arriate
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Kiro Grifols business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Robotic Compounding Hardware: Sale of robotic compounding systems (KIRO Oncology, KIRO Fill, Gri-fill, KIRO Isolator) which are major capital equipment investments for hospital pharmacies. Systems include deployment, qualification, and periodic maintenance services.
- Software and Services: KIRO Link software for workflow management, analytics, training, and service desk. Ongoing maintenance, qualification, and periodic maintenance services for deployed systems.
- Professional Services: Deployment, qualification, and ongoing maintenance services. Includes dosing accuracy tests, airflow certifications, USP <797> compliance support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing based on hospital requirements |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
Kiro Grifols product offering
Product offeringCore offering
Kiro Grifols designs, manufactures and sells robotic and automated compounding systems (KIRO Oncology, KIRO Fill, Gri-fill, KIRO Isolator) plus the KIRO Link workflow management software for hospital pharmacies. The systems automate the sterile compounding of hazardous (e.g., chemotherapy/oncology) and non-hazardous IV medications, combining robotic arms, gravimetric verification, barcode/RFID identification and HIS/EMR integration, and are sold with deployment, qualification and maintenance services.
Product overview
Kiro Grifols is part of the inclusiv portfolio, a comprehensive IV compounding portfolio of integrated technology, software, and service solutions designed to enhance patient safety in sterile compounding environments. The company's product portfolio includes: KIRO Oncology (robotic compounding system for hazardous drug preparation), KIRO Fill (automated compounding device for non-hazardous sterile preparations), Gri-fill (semi-automatic compounding system for batch and patient-specific production), KIRO Isolator (VPH sterilization robotic compounding system), and KIRO Link (web-based pharmacy workflow management software that integrates all devices). Together, these products provide end-to-end solutions for hospital pharmacy IV compounding from automated preparation to workflow management and analytics.
Differentiator
Problem solved
Functional benefit
Products and services
- KIRO Oncology Robotic compounding system that automates the sterile preparation of hazardous drugs (e.g., chemotherapy/oncology IV medications) for hospital pharmacies. Features two robotic arms, a 12-position vial carousel, gravimetric verification, barcode readers, cameras, enclosed self-cleaning, HIS interface and CSTD compatibility, designed to improve dosing accuracy, sterility and staff protection.
- KIRO Fill Automated compounding device that produces non-hazardous compounded sterile preparations (IV admixtures, syringes, infusion bags) for hospital pharmacies. Features parallel automated units, gravimetric control, RFID tracking, barcode scanning, ISO 5 aseptic environment with HEPA H14 filtration, automatic capping, simultaneous loading/unloading/compounding and HIS integration in a compact footprint.
- Gri-fill Semi-automatic compounding system for batch and patient-specific production of both non-hazardous and hazardous compounded sterile preparations. Uses volumetric and peristaltic pump dosing, performs in-process checks and validation, supports reconstitution and diluent withdrawal, fits inside a biosafety cabinet or isolator, manages multiple final container types and integrates with hospital information systems.
- KIRO Isolator Robotic compounding system that combines vaporized hydrogen peroxide (VHP) sterilization with robotic compounding to provide automated aseptic processing. Includes material sterilization in an entry airlock, a preparation bay for up to 10 infusion bags, a syringe capping station and physical isolation of operators from hazardous drugs to support USP <800> compliance.
- KIRO Link Web-based pharmacy workflow management software that connects Kiro Grifols compounding devices with hospital information systems. Provides bidirectional HL7 HIS integration, a production management dashboard, drug master data management, KIRO Analytics productivity reporting, a digital training and competency platform, KIRO Network user community and a customer service desk.
Quantifiable outcome
- KIRO Oncology self-cleaning system achieves 99.8% or greater decontamination efficacy for nine common cytotoxic drugs (5-fluorouracil, ifosfamide, cyclophosphamide, gemcitabine, etoposide, methotrexate, paclitaxel, docetaxel, carboplatin)
- +4 more outcomes
Companies that use Kiro Grifols
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles2 records
Kiro Grifols technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature5 records
Kiro Grifols partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- GrifolscoreGrifols acquired Kiro Robotics SL in 2014 and rebranded it as Kiro Grifols SL. All Kiro products are part of inclusiv portfolio and integrated into Grifols Healthcare Solutions. Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving health and well-being in more than 110 countries.
Scale indicators2 records
Recent moves7 records
Expansion highlights4 records
Kiro Grifols competitors and assessment
Company assessmentBroad incumbents
- Fresenius Kabi: Fresenius Kabi supplies IV drugs, infusion devices, and compounding-related consumables to the same hospital pharmacy customers that purchase KIRO systems, making it a relevant adjacent player in sterile compounding workflows.
- Omnicell: Omnicell is a dominant player in pharmacy and medication management automation; its central pharmacy IV compounding and inventory solutions overlap with the hospital pharmacy segment Kiro serves, even though its core strength is unit-dose dispensing automation.
- B. Braun: B. Braun offers compounding and IV admixture solutions (e.g., APEX compounding system) targeting hospital pharmacies; as a broad medical device incumbent with global sales force, it is comparable on customer base and pharmacy compounding workflow, though not specialized in robotics.
Direct peers
- ICU Medical: ICU Medical's pharmacy compounding and IV workflow solutions (including legacy Hospira/ICU technologies) compete directly with Kiro's automated compounding portfolio for hospital pharmacy automation budgets.
- Baxter International (DoseEdge): Baxter's DoseEdge is a leading pharmacy IV workflow and compounding management system that competes with KIRO Link and serves the same hospital pharmacy dosing/compounding use cases that Kiro targets with both hardware and software.
- ARxIUM (RIVA): ARxIUM's RIVA system is one of the most established fully automated robotic IV compounding platforms for hazardous and non-hazardous sterile preparations; it competes head-to-head with KIRO Oncology and KIRO Fill for hospital pharmacy automation contracts.
Regional players
- Yuyama Co., Ltd. Yuyama is a major Japanese pharmacy automation manufacturer with compounding and dispensing equipment; comparable on technology and use case, but its primary geographic footprint is Asia, distinct from Kiro's Europe-centric sales footprint.
Emerging players
- Health Robotics (now part of Loccioni / independent): Health Robotics developed i.v.STATION, an early robotic IV compounding system, putting it in direct product/technology competition with KIRO Oncology for hazardous drug preparation automation in hospital pharmacies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Kiro Grifols social profiles
Digital presenceKiro Grifols compliance and trust
Trust signalCompliance11 records
Kiro Grifols financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kiro Grifols leadership team
Management profileNumber of profiles
Kiro Grifols funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kiro Grifols M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kiro Grifols
What does Kiro Grifols do?
Kiro Grifols designs, manufactures and sells robotic and automated compounding systems (KIRO Oncology, KIRO Fill, Gri-fill, KIRO Isolator) plus the KIRO Link workflow management software for hospital pharmacies. The systems automate the sterile compounding of hazardous (e.g., chemotherapy/oncology) and non-hazardous IV medications, combining robotic arms, gravimetric verification, barcode/RFID identification and HIS/EMR integration, and are sold with deployment, qualification and maintenance services.
Is Kiro Grifols a public or private company?
Kiro Grifols is a private company. It is classified as corporate owned and is currently operating.
When was Kiro Grifols founded?
Kiro Grifols was founded in 2010. It employs 51 to 100 people.
Where is Kiro Grifols based?
Kiro Grifols is headquartered in Arriate, Spain, in the Europe region.
How does Kiro Grifols make money?
Three revenue lines are on record. Robotic Compounding Hardware is the primary driver. The others are software and Services and professional Services.
Who are Kiro Grifols's main competitors?
Broad incumbents on record are Fresenius Kabi, Omnicell and B. Braun. Direct peers are ICU Medical, Baxter International (DoseEdge) and ARxIUM (RIVA). Yuyama Co., Ltd. is listed as a regional player. Health Robotics (now part of Loccioni / independent) is listed as an emerging player.
Does Kiro Grifols have an API?
No public API is recorded for Kiro Grifols.
What industry is Kiro Grifols in?
Kiro Grifols's product category is Hospital Pharmacy Sterile Compounding Automation. Its primary akta.pro industry code is HLACAKAM, Compounding Pharmacy & Sterile Prep Workflow Systems, with a secondary code of HLACAKAC, Pharmacy Information Systems (PIS) & Dispensing Workflow. Its NAICS code is 339112 and its SIC code is 3841.